title: [Cardiotoxicity of trastuzumab in the adjuvant treatment of breast cancer patients : Results of the NCCTG N9831 trial].
authors.affiliation: Klinik für RadioOnkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. David.Krug@med.uni-heidelberg.de.
authors.forename: David
authors.initials: D
authors.lastname: Krug
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000628:therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D059186:Chemoradiotherapy, Adjuvant / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D000068878:Trastuzumab / Q000009:adverse effects* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000068878:Trastuzumab